BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21963461)

  • 21. Association of MMP-9 gene polymorphisms with atrial fibrillation in hypertensive heart disease patients.
    Gai X; Lan X; Luo Z; Wang F; Liang Y; Zhang H; Zhang W; Hou J; Huang M
    Clin Chim Acta; 2009 Oct; 408(1-2):105-9. PubMed ID: 19665460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease].
    Gao B; Li ZC
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
    Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
    Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI.
    Fiotti N; Altamura N; Orlando C; Simi L; Reimers B; Pascotto P; Zingone B; Pascotto A; Serio M; Guarnieri G; Giansante C
    Int J Cardiol; 2008 Jul; 127(3):350-7. PubMed ID: 17706812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.
    Chen F; Eriksson P; Hansson GK; Herzfeld I; Klein M; Hansson LO; Valen G
    Int J Mol Med; 2005 Jan; 15(1):57-65. PubMed ID: 15583828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease].
    Shevchenko AV; Golovanova OV; Konenkov VI; Tolkacheva OM; Maksimov VN; Voevoda MI; Romashchenko AG
    Ter Arkh; 2010; 82(1):31-4. PubMed ID: 20364697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects.
    Demacq C; de Souza AP; Machado AA; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2006 Mar; 365(1-2):183-7. PubMed ID: 16168399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
    Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Lacchini R; Gerlach RF; Passos CJ; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2011 Sep; 409(20):4242-6. PubMed ID: 21794897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RANTES -403G>A promoter polymorphism in Korean men: association with serum RANTES concentration and coronary artery disease.
    Jang Y; Chae JS; Hyun YJ; Koh SJ; Kim JY; Ko MJ; Rim SJ; Shin HJ; Ordovas JM; Lee JH
    Clin Sci (Lond); 2007 Oct; 113(8):349-56. PubMed ID: 17504241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gelatinase B C(-1562)T polymorphism in relation to ischaemic heart disease.
    Haberbosch W; Gardemann A
    Scand J Clin Lab Invest; 2005; 65(6):513-22. PubMed ID: 16179285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction.
    Seckin D; Ilhan N; Ilhan N; Ozbay Y
    Clin Biochem; 2006 Jan; 39(1):50-4. PubMed ID: 16303122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM; Sun TY; Lin JB; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
    Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RANTES gene mRNA expression and its -403 G/A promoter polymorphism in coronary artery disease.
    Tavakkoly-Bazzaz J; Amiri P; Tajmir-Riahi M; Javidi D; Khojasteh-Fard M; Taheri Z; Tabrizi A; Keramatipour M; Amoli MM
    Gene; 2011 Nov; 487(1):103-6. PubMed ID: 21839152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.
    Wang L; Ma YT; Xie X; Yang YN; Fu ZY; Li XM; Liu F; Huang Y; Ma X; Chen BD; Yuan S; Sun MH; Peng X; Wang BZ
    Clin Appl Thromb Hemost; 2012; 18(1):72-8. PubMed ID: 21733941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
    Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers.
    Singh K; Agrawal NK; Gupta SK; Singh K
    Int J Low Extrem Wounds; 2013 Sep; 12(3):199-204. PubMed ID: 24043671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.